MPR delivers practical, up-to-date drug information to healthcare professionals. Using the expertise gained from 25 years of providing point-of-care drug tools, MPR has now created a drug review course exclusively for See below for a list of each quarter's courses. Click here to visit MPR's website.

Latest Courses

Clinical Review

New-Drug Review from MPR (April 2014)

1.00 Credits
Clinical Review

New Drug Review from MPR (October 2013)

1.00 Credits

Archived CME/CE Courses


MPR Drug News

FDA Clears New Flu, RSV Dx Molecular Test

Cepheid announced it has received clearance from the Food and Drug Administration (FDA) to market Xpert Flu/RSV XC, a molecular test for determination for Flu A and B, and differentiation of respiratory syncytial virus (RSV) infection.

FDA Grants QDIP Status to Two Inhalation Products

The Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP) to two Bayer Healthcare products, Amikacin Inhale and Ciprofloxacin Dry Powder for Inhalation (DPI).

New Clinical Guidelines Issued for Paget's Disease

The Endocrine Society released a Clinical Practice Guideline for the diagnosis and treatment of Paget's disease of the bone.

Smartphone App to Monitor Opioid Addiction Tx: Clinical Trial Begins

AiCure announced the initiation of a major clinical trial assessing the company's advanced facial recognition and motion-sensing technology to monitor and intervene with patients on maintenance therapy for opioid addiction.

Laparoscopic Power Morcellators Get Safety Labeling Update

The Food and Drug Administration (FDA) is warning against the use of laparoscopic power morcellators in hysterectomy or myomectomy procedures for the majority of women.